Discovery and Optimization of Novel Nonbile Acid FXR Agonists as Preclinical Candidates for the Treatment of Inflammatory Bowel Disease.
Li Y, Xu T, Zhao Y, Zhang H, Liu Z, Wang H, Huang C, Shu Z, Gao L, Xie R, Jiao T, Zhang D, Zhang D, Liang X, Zang Y, Sun Y, Liu H, Li J, Zhou Y.
Li Y, et al. Among authors: sun y.
J Med Chem. 2024 Apr 11;67(7):5642-5661. doi: 10.1021/acs.jmedchem.3c02304. Epub 2024 Mar 28.
J Med Chem. 2024.
PMID: 38547240